COMPANY

Targazyme, Inc.

HQ: Carlsbad, CA source · targazyme.com ↗ · West Coast

Keywords: cell therapy Blood And Marrow Transplantation Leukemia Lymphoma Transplantation Infection Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Hodgkin's Lymphoma diabetes

Location: Carlsbad, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)9NIH grants

Timeline

2013-11 Trial start Phase 1/Phase 2: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT01983761	Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation	Phase 1/Phase 2	Unknown status (ClinicalTrials.gov)	2013-11	2014-03 (estimated)

NIH awards 9

Annual award amounts. Total $3.3M.

Aug 25, 2016 NIH award 5R44CA192601-02 FY2016: $467,137 awarded for that fiscal year; activity R44 (SBIR); PI FLAIM, JOANN; recipient as written: TARGAZYME, INC., CARLSBAD, CA. A Phase I/II Clinical Trial to Investigate Fucosylat source ↗
Aug 31, 2015 NIH award 1R44CA192601-01A1 FY2015: $1,059,489 awarded for that fiscal year; activity R44 (SBIR); PI FLAIM, JOANN; recipient as written: TARGAZYME, INC., CARLSBAD, CA. A Phase I/II Clinical Trial to Investigate Fucos source ↗
Jul 24, 2014 NIH award 1R43EY023463-01A1 FY2014: $215,739 awarded for that fiscal year; activity R43 (SBIR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. Novel cell-based Restorative Approach in Trea source ↗
Jul 8, 2014 NIH award 1R43DE024410-01A1 FY2014: $224,932 awarded for that fiscal year; activity R43 (SBIR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. Therapeutic Potential & Targeted Homing of EC source ↗
Dec 21, 2012 NIH award 1R43NS079027-01A1 FY2013: $335,440 awarded for that fiscal year; activity R43 (SBIR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. Increased Therapeutic Potential of Migrating source ↗
Aug 15, 2012 NIH award 1R41HL112461-01 FY2012: $156,754 awarded for that fiscal year; activity R41 (STTR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. ASC101 Enhancement of Regenerative Capacity of source ↗
Aug 12, 2011 NIH award 1R43HL110692-01 FY2011: $347,580 awarded for that fiscal year; activity R43 (SBIR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. Ex Vivo Fucosylation of Cord Blood with FTVII & source ↗
Aug 9, 2011 NIH award 1R43HL102995-01A1 FY2011: $290,908 awarded for that fiscal year; activity R43 (SBIR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. Enhanced Engraftment with Fucosylation of Cor source ↗
Sep 9, 2008 NIH award 1R43CA139602-01 FY2008: $193,658 awarded for that fiscal year; activity R43 (SBIR); PI MILLER, LEONARD P; recipient as written: TARGAZYME, INC., CARLSBAD, CA. Novel Approach to Enhance Cord Blood-Mediated B source ↗